Yahoo Finance

Operations: The company generates revenue of CN¥4.46 billion from its biotechnology segment, which involves bioactive material-based beauty and health products in China.

Estimated Discount To Fair Value: 49.7%

Giant Biogene Holding, trading at HK$52.4, is significantly undervalued with a fair value estimate of HK$104.12. Despite past shareholder dilution, its earnings grew by 68.1% last year and are expected to grow significantly at 23.5% annually, surpassing the Hong Kong market's average growth rate of 11.2%. Revenue is projected to increase by 19.4% per year, also outpacing market averages, indicating robust cash flow potential despite moderate revenue growth forecasts.

• Upon reviewing our latest growth report, Giant Biogene Holding's projected financial performance appears quite optimistic.

• Delve into the full analysis health report here for a deeper understanding of Giant Biogene Holding.

Range Intelligent Computing Technology Group

Overview: Range Intelligent Computing Technology Group Company Limited develops data centers and technology campuses, with a market cap of CN¥93.99 billion.

Operations: The company's revenue from IDC Services amounts to CN¥8.08 billion.

Estimated Discount To Fair Value: 11.2%

Range Intelligent Computing Technology Group, trading at CN¥52.37, is undervalued with a fair value estimate of CN¥58.96. Recent earnings reports show substantial growth in revenue and net income over the past year, though profit margins have decreased from 44% to 26.7%. Earnings are expected to grow significantly at 30.6% annually, outpacing the Chinese market's average growth rate of 25%. However, debt coverage by operating cash flow remains inadequate.

• According our earnings growth report, there's an indication that Range Intelligent Computing Technology Group might be ready to expand.

• Click here and access our complete balance sheet health report to understand the dynamics of Range Intelligent Computing Technology Group.

Seize The Opportunity

• Dive into all 870 of the Undervalued Stocks Based On Cash Flows we have identified here.

• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.

• Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SEHK:1415 SEHK:2367 and SZSE:300442.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com